Primary |
Drug Use For Unknown Indication |
23.7% |
Pneumonia |
10.1% |
Pulmonary Tuberculosis |
7.8% |
Prophylaxis |
7.4% |
Sepsis |
7.1% |
Anaesthesia |
6.8% |
Bronchitis |
4.7% |
Tuberculosis |
3.7% |
Chronic Obstructive Pulmonary Disease |
3.5% |
Hypertension |
3.4% |
Upper Respiratory Tract Infection |
3.4% |
Sinusitis |
2.8% |
Pain |
2.7% |
Septic Shock |
2.6% |
Infection |
2.1% |
Bradycardia |
1.7% |
Infection Prophylaxis |
1.7% |
Product Used For Unknown Indication |
1.7% |
Respiratory Tract Infection |
1.7% |
Atypical Mycobacterial Infection |
1.4% |
|
Vomiting |
11.0% |
Rash |
8.4% |
Bradycardia |
7.1% |
Pyrexia |
7.1% |
Clostridium Difficile Colitis |
6.5% |
Thrombocytopenia |
6.5% |
Urticaria |
6.5% |
Torsade De Pointes |
5.2% |
International Normalised Ratio Increased |
4.5% |
Renal Failure Acute |
4.5% |
Ventricular Tachycardia |
4.5% |
Pneumonia Aspiration |
3.9% |
Tendonitis |
3.9% |
Diarrhoea |
3.2% |
Rhabdomyolysis |
3.2% |
Wheezing |
3.2% |
Clostridial Infection |
2.6% |
Hypotension |
2.6% |
Tachycardia |
2.6% |
Uveitis |
2.6% |
|
Secondary |
Product Used For Unknown Indication |
21.7% |
Drug Use For Unknown Indication |
19.8% |
Pneumonia |
7.9% |
Sepsis |
5.6% |
Rheumatoid Arthritis |
4.9% |
Septic Shock |
4.1% |
Respiratory Tract Infection |
3.8% |
Bronchitis |
3.6% |
Mycobacterial Infection |
3.6% |
Pulmonary Tuberculosis |
3.4% |
Hiv Infection |
3.0% |
Pneumonia Legionella |
2.6% |
Hypertension |
2.4% |
Anaesthesia |
2.3% |
Pain |
2.1% |
Prophylaxis |
2.1% |
Atrial Fibrillation |
1.9% |
Chronic Obstructive Pulmonary Disease |
1.9% |
Disseminated Tuberculosis |
1.7% |
Ill-defined Disorder |
1.7% |
|
International Normalised Ratio Increased |
9.6% |
Bradycardia |
8.5% |
Thrombocytopenia |
8.5% |
Pneumonia |
7.4% |
Renal Failure |
7.4% |
Clostridium Difficile Colitis |
6.4% |
Urticaria |
6.4% |
Vomiting |
6.4% |
Rhabdomyolysis |
5.3% |
Cytolytic Hepatitis |
4.3% |
Electrocardiogram Qt Prolonged |
4.3% |
Drug Exposure During Pregnancy |
3.2% |
Drug Rash With Eosinophilia And Systemic Symptoms |
3.2% |
Sudden Death |
3.2% |
Tendon Rupture |
3.2% |
Vertigo |
3.2% |
Xerophthalmia |
3.2% |
Corneal Deposits |
2.1% |
Diarrhoea |
2.1% |
Hypersensitivity |
2.1% |
|
Concomitant |
Drug Use For Unknown Indication |
53.5% |
Prophylaxis |
4.1% |
Multiple Myeloma |
3.9% |
Pain |
3.9% |
Pneumonia |
3.5% |
Hiv Infection |
3.3% |
Non-small Cell Lung Cancer |
3.0% |
Tuberculosis |
2.7% |
Product Used For Unknown Indication |
2.7% |
Hypertension |
2.6% |
Constipation |
2.3% |
Acute Lymphocytic Leukaemia |
1.9% |
Acute Myeloid Leukaemia |
1.9% |
Nausea |
1.8% |
Asthma |
1.5% |
Pulmonary Tuberculosis |
1.5% |
Breast Cancer |
1.4% |
Infection |
1.4% |
Thrombosis Prophylaxis |
1.4% |
Renal Transplant |
1.4% |
|
Vomiting |
12.7% |
Pyrexia |
8.5% |
Weight Decreased |
7.7% |
White Blood Cell Count Decreased |
7.0% |
Renal Failure Acute |
5.6% |
Sepsis |
5.6% |
Toxic Epidermal Necrolysis |
5.6% |
White Blood Cell Count Increased |
5.6% |
Respiratory Failure |
4.9% |
Somnolence |
4.9% |
Urticaria |
4.2% |
Viral Haemorrhagic Cystitis |
4.2% |
Thrombocytopenia |
3.5% |
Hypoxia |
2.8% |
International Normalised Ratio Increased |
2.8% |
Prostate Cancer |
2.8% |
Pulmonary Embolism |
2.8% |
Rash Vesicular |
2.8% |
Renal Failure |
2.8% |
Serotonin Syndrome |
2.8% |
|
Interacting |
Pneumonia |
31.1% |
Breast Cancer Metastatic |
16.4% |
Pain |
9.8% |
Prophylaxis Against Gastrointestinal Ulcer |
8.2% |
Renal Failure Chronic |
8.2% |
Mitral Valve Replacement |
6.6% |
Drug Use For Unknown Indication |
4.9% |
Lung Infection |
4.9% |
Pyrexia |
3.3% |
Anticoagulant Therapy |
1.6% |
Depression |
1.6% |
Respiratory Tract Infection |
1.6% |
Thrombosis Prophylaxis |
1.6% |
|
International Normalised Ratio Increased |
33.3% |
Pseudomembranous Colitis |
33.3% |
Drug Interaction |
8.3% |
Electrocardiogram Qt Prolonged |
8.3% |
Peritoneal Haemorrhage |
8.3% |
Urinary Tract Infection |
8.3% |
|